Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities

Advances in our understanding of the role of magnetic resonance imaging (MRI) for the detection of prostate cancer have enabled its integration into clinical routines in the past two decades. The Prostate Imaging Reporting and Data System (PI-RADS) is an established imaging-based scoring system that...

Full description

Bibliographic Details
Main Authors: Huanye Li, Chau Hung Lee, David Chia, Zhiping Lin, Weimin Huang, Cher Heng Tan
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/2/289
_version_ 1797481288247017472
author Huanye Li
Chau Hung Lee
David Chia
Zhiping Lin
Weimin Huang
Cher Heng Tan
author_facet Huanye Li
Chau Hung Lee
David Chia
Zhiping Lin
Weimin Huang
Cher Heng Tan
author_sort Huanye Li
collection DOAJ
description Advances in our understanding of the role of magnetic resonance imaging (MRI) for the detection of prostate cancer have enabled its integration into clinical routines in the past two decades. The Prostate Imaging Reporting and Data System (PI-RADS) is an established imaging-based scoring system that scores the probability of clinically significant prostate cancer on MRI to guide management. Image fusion technology allows one to combine the superior soft tissue contrast resolution of MRI, with real-time anatomical depiction using ultrasound or computed tomography. This allows the accurate mapping of prostate cancer for targeted biopsy and treatment. Machine learning provides vast opportunities for automated organ and lesion depiction that could increase the reproducibility of PI-RADS categorisation, and improve co-registration across imaging modalities to enhance diagnostic and treatment methods that can then be individualised based on clinical risk of malignancy. In this article, we provide a comprehensive and contemporary review of advancements, and share insights into new opportunities in this field.
first_indexed 2024-03-09T22:12:43Z
format Article
id doaj.art-c55be45af25f43ce8d3c21ac34af25a4
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T22:12:43Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-c55be45af25f43ce8d3c21ac34af25a42023-11-23T19:29:33ZengMDPI AGDiagnostics2075-44182022-01-0112228910.3390/diagnostics12020289Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future OpportunitiesHuanye Li0Chau Hung Lee1David Chia2Zhiping Lin3Weimin Huang4Cher Heng Tan5School of Electrical and Electronic Engineering, Nanyang Technological University, Singapore 639798, SingaporeDepartment of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore 308433, SingaporeDepartment of Radiation Oncology, National University Cancer Institute (NUH), Singapore 119074, SingaporeSchool of Electrical and Electronic Engineering, Nanyang Technological University, Singapore 639798, SingaporeInstitute for Infocomm Research, A*Star, Singapore 138632, SingaporeDepartment of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore 308433, SingaporeAdvances in our understanding of the role of magnetic resonance imaging (MRI) for the detection of prostate cancer have enabled its integration into clinical routines in the past two decades. The Prostate Imaging Reporting and Data System (PI-RADS) is an established imaging-based scoring system that scores the probability of clinically significant prostate cancer on MRI to guide management. Image fusion technology allows one to combine the superior soft tissue contrast resolution of MRI, with real-time anatomical depiction using ultrasound or computed tomography. This allows the accurate mapping of prostate cancer for targeted biopsy and treatment. Machine learning provides vast opportunities for automated organ and lesion depiction that could increase the reproducibility of PI-RADS categorisation, and improve co-registration across imaging modalities to enhance diagnostic and treatment methods that can then be individualised based on clinical risk of malignancy. In this article, we provide a comprehensive and contemporary review of advancements, and share insights into new opportunities in this field.https://www.mdpi.com/2075-4418/12/2/289prostate MRIcancerdeep learningmachine learningPI-RADSsegmentation
spellingShingle Huanye Li
Chau Hung Lee
David Chia
Zhiping Lin
Weimin Huang
Cher Heng Tan
Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
Diagnostics
prostate MRI
cancer
deep learning
machine learning
PI-RADS
segmentation
title Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
title_full Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
title_fullStr Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
title_full_unstemmed Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
title_short Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
title_sort machine learning in prostate mri for prostate cancer current status and future opportunities
topic prostate MRI
cancer
deep learning
machine learning
PI-RADS
segmentation
url https://www.mdpi.com/2075-4418/12/2/289
work_keys_str_mv AT huanyeli machinelearninginprostatemriforprostatecancercurrentstatusandfutureopportunities
AT chauhunglee machinelearninginprostatemriforprostatecancercurrentstatusandfutureopportunities
AT davidchia machinelearninginprostatemriforprostatecancercurrentstatusandfutureopportunities
AT zhipinglin machinelearninginprostatemriforprostatecancercurrentstatusandfutureopportunities
AT weiminhuang machinelearninginprostatemriforprostatecancercurrentstatusandfutureopportunities
AT cherhengtan machinelearninginprostatemriforprostatecancercurrentstatusandfutureopportunities